US 8802856
Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 8802856 (Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00